Data-Driven Trials Report: Cross-Border Sites, Oncology, RbM HF/MDD
Practical guidance for cross-border academic coordination, oncology enrollment during awareness months, and risk-based monitoring for heart failure and MDD—grounded in recent FDA/EMA guidance and operational insider insight.
Robert Maxwell
Sep 29, 2025
breast cancer trials
heart failure trials
pregnancy exposure registries
Phrenic nerve stimulation
